150 related articles for article (PubMed ID: 24324063)
1. Silicate fiber-based 3D cell culture system for anticancer drug screening.
Yamaguchi Y; Deng D; Sato Y; Hou YT; Watanabe R; Sasaki K; Kawabe M; Hirano E; Morinaga T
Anticancer Res; 2013 Dec; 33(12):5301-9. PubMed ID: 24324063
[TBL] [Abstract][Full Text] [Related]
2. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
3. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
Breslin S; O'Driscoll L
Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
[TBL] [Abstract][Full Text] [Related]
4. Activity of anticancer agents in a three-dimensional cell culture model.
Nirmalanandhan VS; Duren A; Hendricks P; Vielhauer G; Sittampalam GS
Assay Drug Dev Technol; 2010 Oct; 8(5):581-90. PubMed ID: 20662735
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
Dhiman HK; Ray AR; Panda AK
Biomaterials; 2005 Mar; 26(9):979-86. PubMed ID: 15369686
[TBL] [Abstract][Full Text] [Related]
7. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
Subia B; Dey T; Sharma S; Kundu SC
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
[TBL] [Abstract][Full Text] [Related]
8. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
9. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effects of crab derived exosomes and doxorubicin in 2 & 3-dimensional in vivo models of breast cancer.
Rezakhani L; Rahmati S; Ghasemi S; Alizadeh M; Alizadeh A
Chem Phys Lipids; 2022 Mar; 243():105179. PubMed ID: 35150707
[TBL] [Abstract][Full Text] [Related]
11. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
13. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation.
Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Heebkaew N; Rujanapun N; Noisa P
J Cell Physiol; 2019 Nov; 234(11):20085-20097. PubMed ID: 30945284
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.
Zhang X; Wang W; Yu W; Xie Y; Zhang X; Zhang Y; Ma X
Biotechnol Prog; 2005; 21(4):1289-96. PubMed ID: 16080713
[TBL] [Abstract][Full Text] [Related]
16. The role of the 3D environment in hypoxia-induced drug and apoptosis resistance.
Kim JW; Ho WJ; Wu BM
Anticancer Res; 2011 Oct; 31(10):3237-45. PubMed ID: 21965731
[TBL] [Abstract][Full Text] [Related]
17. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
[TBL] [Abstract][Full Text] [Related]
18. A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening.
Rijal G; Li W
Sci Adv; 2017 Sep; 3(9):e1700764. PubMed ID: 28924608
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans ET; Doijen J; Luyten W; Landuyt B; Schoofs L
J Cell Physiol; 2018 Apr; 233(4):2993-3003. PubMed ID: 28618001
[TBL] [Abstract][Full Text] [Related]
20. Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.
Li X; Zhang X; Zhao S; Wang J; Liu G; Du Y
Lab Chip; 2014 Feb; 14(3):471-81. PubMed ID: 24287736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
